These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20621297)

  • 1. Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris.
    Pedersen ER; Ueland T; Seifert R; Aukrust P; Schartum-Hansen H; Ebbing M; Bleie Ø; Igland J; Svingen G; Nordrehaug JE; Nygård O
    Atherosclerosis; 2010 Oct; 212(2):644-9. PubMed ID: 20621297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes.
    Omland T; Ueland T; Jansson AM; Persson A; Karlsson T; Smith C; Herlitz J; Aukrust P; Hartford M; Caidahl K
    J Am Coll Cardiol; 2008 Feb; 51(6):627-33. PubMed ID: 18261681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
    Fuernau G; Zaehringer S; Eitel I; de Waha S; Droppa M; Desch S; Schuler G; Adams V; Thiele H
    Int J Cardiol; 2013 Sep; 167(5):2134-9. PubMed ID: 22704876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography.
    Ghaffari S; Yaghoubi A; Baghernejad R; Sepehrvand N; Sokhanvar S; Haghjou AG
    Cardiol J; 2013; 20(3):261-7. PubMed ID: 23788300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Pedersen S; Mogelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Sørensen TB; Iversen A; Hvelplund A; Jensen JS
    Cardiology; 2012; 123(1):31-8. PubMed ID: 22964478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?
    Hosbond SE; Diederichsen AC; Saaby L; Rasmussen LM; Lambrechtsen J; Munkholm H; Sand NP; Gerke O; Poulsen TS; Mickley H
    Atherosclerosis; 2014 Oct; 236(2):230-6. PubMed ID: 25104079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
    Dunder K; Lind L; Lagerqvist B; Zethelius B; Vessby B; Lithell H
    Am Heart J; 2004 Mar; 147(3):502-8. PubMed ID: 14999201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma osteoprotegerin levels and long-term prognosis in patients with intermediate coronary artery lesions.
    Yang Q; Lu S; Chen Y; Song X; Jin Z; Yuan F; Li H; Zhou Y; Chen F; Huo Y
    Clin Cardiol; 2011 Jul; 34(7):447-53. PubMed ID: 21678453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial.
    Bjerre M; Hilden J; Kastrup J; Skoog M; Hansen JF; Kolmos HJ; Jensen GB; Kjøller E; Winkel P; Flyvbjerg A; Gluud C;
    Scand J Clin Lab Invest; 2014 Nov; 74(8):657-64. PubMed ID: 25026506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients.
    Koo HM; Do HM; Kim EJ; Lee MJ; Shin DH; Kim SJ; Oh HJ; Yoo DE; Kim JK; Park JT; Han SH; Kang SW; Choi KH; Yoo TH
    Atherosclerosis; 2011 Dec; 219(2):925-30. PubMed ID: 22015178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
    Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N
    Heart; 2006 Feb; 92(2):177-82. PubMed ID: 15951393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum osteoprotegerin in young survivors of myocardial infarction.
    Vik A; Brodin E; Børvik T; Sveinbjørnsson B; Hansen JB
    Thromb Haemost; 2006 May; 95(5):881-5. PubMed ID: 16676081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
    Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
    J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris.
    Strand E; Pedersen ER; Svingen GF; Olsen T; Bjørndal B; Karlsson T; Dierkes J; Njølstad PR; Mellgren G; Tell GS; Berge RK; Svardal A; Nygård O
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty].
    Araki T; Kanaya H; Shimizu M; Mabuchi H; Kitayama M; Kanemitsu S; Takekoshi N;
    J Cardiol; 2001 Aug; 38(2):55-60. PubMed ID: 11525110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes.
    Jansson AM; Hartford M; Omland T; Karlsson T; Lindmarker P; Herlitz J; Ueland T; Aukrust P; Caidahl K
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3041-9. PubMed ID: 23023373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of plaque calcification regulators osteoprotegerin and matrix Gla-proteins in stable angina and acute myocardial infarction.
    Margonato A; Gorla R; Macchi A; Buzzetti F; Franzoni I; Pedrigi MC; Rosa I; Sirtori M; Villa I; Rubinacci A
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):156-62. PubMed ID: 24566391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris.
    Avanzas P; Arroyo-Espliguero R; Quiles J; Roy D; Kaski JC
    Eur Heart J; 2005 Mar; 26(5):457-63. PubMed ID: 15684278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Li LF
    Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.